Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the management of metabolic disorders. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://theoxftx912271.fitnell.com/79812502/retaglutide-a-promising-glp-1-receptor-agonist